Reaktionsgleichung
[N:1]1([C:13](=[O:14])[C:12]2[N:10]([CH3:11])[CH:9]=[N:8][C:7]=2[N:5]([CH3:6])[C:3]1=[O:4])C.C[N:16]1[C:25](=[O:26])[C:24]2[N:23]([CH2:27][CH2:28][CH3:29])[CH:22]=[N:21][C:20]=2[N:19]([CH3:30])[C:17]1=[O:18]>>[NH:1]1[C:13](=[O:14])[C:12]2[N:10]([CH3:11])[CH:9]=[N:8][C:7]=2[N:5]([CH3:6])[C:3]1=[O:4].[CH3:30][N:19]1[C:20]2[N:21]=[CH:22][N:23]([CH2:27][CH2:28][CH3:29])[C:24]=2[C:25](=[O:26])[NH:16][C:17]1=[O:18]Komponenten
4
Versuchsvorschrift
The 1,3-methyl-7-alkylxanthine was thus converted to the corresponding 3-methyl-7-alkylxanthine. The results of the conversion reaction are shown in FIG. 2. It is seen that in using either of the substrates (caffeine or 1,3-dimethyl-7-propylxanthine) the transformant strain having pCA32A, i.e., P. putida IF-3-9C-21/pCA32A, produces the corresponding conversion product (theobromine or 3-methyl-7-propylxanthine, respectively) in an amount about 2 to 4 times that produced by P. putida IF-3-9C-21.
Aufarbeitung
- customThe results of the conversion reaction
Quellen und Nachweise
- ORD-Eintrag
- ord-e7715a4264d447d7b0318a6d2f6a1836
- Quelldatensatz
- uspto-grants-1996_08
- Patentnummer
- US05550041
Verknüpfte Notizen
Wird geladen…